Objective:

To explore the relationship between CADASIL and multiple sclerosis (MS) and its clinical implications through case reports and a literature review.

Approach:

Key Findings:

• CADASIL can present with clinical and radiological features similar to MS, leading to misdiagnosis, which may delay appropriate treatment.
• Some patients with CADASIL showed atypical features for both MS and CADASIL, complicating diagnosis.
• The study identified 12 relevant reports linking CADASIL and MS, highlighting the need for awareness among clinicians.

Interpretation:

The findings raise questions about the potential for CADASIL to predispose to MS-like manifestations and suggest a need for revised treatment approaches in affected patients.

Limitations:

• The study relies on previously published case reports, which may vary in quality and detail, potentially introducing bias.
• The sample size is limited to two cases and 12 literature reports, which may not be representative.

Conclusion:

Further research is needed to clarify the relationship between CADASIL and MS, particularly regarding diagnostic criteria, treatment options, and the identification of red flags for genetic testing.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.